The TCGA database indicated that patients with higher stages (stage 3/4) of osteosarcoma exhibited significantly elevated levels of CCL2 expression compared to those observed in lower-stage patients (stage 1/2) (Figure 1A). Here, CCL2 is linked to osteosarcoma.